Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

368

HTML

2938

Figures (1-3)

248

Tables (1-2)

228

Sum=3782

Publishing Process of This Article

Item

Count

Browse

948

Download

991

Sum=1939

Apr 14, 2013 (publication date) through Feb 9, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 14, 2013; 19(14): 2256-2261
Published online Apr 14, 2013. doi: 10.3748/wjg.v19.i14.2256

Table 1 Baseline characteristics of the 232 patients

Characteristics	(n = 232)
Age (yr, mean ± SD)	57.2 ± 10.7
Gender, male/female	89 (38):143 (62)
Weight (kg, mean ± SD)	61.6 ± 9.3
Alcohol consumption	32 (14)
Diabetes	29 (13)
Estimated duration of infection (mo, median, range)	18 (0–398)
Alanine aminotransferase (IU/L, median, quartile)	25 (19–32)
Aspartate aminotransferase (IU/L, median, quartile)	30 (23–48)
Platelet (10³/mm³, median, quartile)	179 (13–224)
Aspartate aminotransferase: platelet ratio index (median, range)	0.4 (0.1–7.5)
> 1	50 (22)
Genotype¹
1b	12 (57)
1 others	1 (5)
2	8 (38)

¹Percent value refers to percentage within studied patients. Data are expressed as absolute numbers (percentage) or mean ± SD.

Citation: Sinn DH, Gwak GY, Shin JU, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels. World J Gastroenterol 2013; 19(14): 2256-2261
URL: https://www.wjgnet.com/1007-9327/full/v19/i14/2256.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i14.2256